MedPath

Altering Bicarbonate Delivery During Hemodialysis to Affect Filtration of Indoxyl Sulfate

Not Applicable
Withdrawn
Conditions
Renal Dialysis
Hemodialysis
Interventions
Drug: Low bicarbonate dialysate First
Drug: Normal bicarbonate dialysate First
Drug: Normal bicarbonate dialysate
Drug: Low bicarbonate dialysate
Registration Number
NCT02639624
Lead Sponsor
NYU Langone Health
Brief Summary

This is a non randomized crossover trial investigating whether changing the pattern of bicarbonate administration during hemodialysis will result in the more efficient filtration of highly protein bound solutes. The experimental group will be dialyzed with low bicarbonate dialysate for the first half of dialysis then switched over to normal bicarbonate dialysate for the second half. The control group will be dialyzed entirely with normal bicarbonate dialysate. The two groups will switch one week late and patients will serve as their own matched controls for a completely standard dialysis and one that is split into two halves with different bicarbonate concentrations.

Detailed Description

Investigators will try to perform dialysis with a low bicarbonate bath which will leave patients blood pH (Hydrogen ion concentration) relatively unchanged then switch to a normal bicarbonate bath during the second half of dialysis so that they attain the pH (Hydrogen ion concentration) they normally would. Investigators will use these measurements to test test the hypothesis that Indoxyl Sulfate (IS) binds to proteins with greater affinity under basic conditions and further to test the hypothesis that it is possible to remove a greater amount of Indoxyl Sulfate (IS) when patients are maintained relatively acidotic during dialysis for a longer period of time due to the greater availability of free IS that can pass through the dialyzer.

Recruitment & Eligibility

Status
WITHDRAWN
Sex
All
Target Recruitment
Not specified
Inclusion Criteria
  • Chronic Stable Dialysis for at least 6 months
Read More
Exclusion Criteria
  • Patients with serum potassium concentration below 4.0 mEq/L on previous monthly lab test or corrected serum calcium below 8.5 mEq/L
  • Hospitalization within the past 12 months
  • Adults unable to consent
  • Children
  • Pregnant women
  • Prisoners
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
Low bicarbonate dialysate FirstLow bicarbonate dialysate FirstDialysis with low bicarbonate dialysate (expected normal for an adult \~24 mEq) for the first half of dialysis then switched over to normal bicarbonate dialysate for the second half.
Low bicarbonate dialysate FirstNormal bicarbonate dialysateDialysis with low bicarbonate dialysate (expected normal for an adult \~24 mEq) for the first half of dialysis then switched over to normal bicarbonate dialysate for the second half.
Normal bicarbonate dialysate FirstNormal bicarbonate dialysate FirstDialysis with normal (37 mEq) for the first half of dialysis then switched over to low bicarbonate dialysate
Normal bicarbonate dialysate FirstLow bicarbonate dialysateDialysis with normal (37 mEq) for the first half of dialysis then switched over to low bicarbonate dialysate
Primary Outcome Measures
NameTimeMethod
Change in the amount of Indoxyl Sulfate level in the first half of dialysis as compared to controls1 Minute, 75 Minutes, 105 Minutes, 180 Minutes, 210 Minutes
Secondary Outcome Measures
NameTimeMethod
Change in pH1 Minute, 75 Minutes, 105 Minutes, 180 Minutes, 210 Minutes

Trial Locations

Locations (1)

New York University School of Medicine

🇺🇸

New York, New York, United States

© Copyright 2025. All Rights Reserved by MedPath